Breaking News

CARsgen Completes cGMP Commercial Manufacturing Facility

The 37,000 sq. ft. facility for clinical and early-stage commercial manufacturing was designed and built in just 12 months.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

CARsgen Therapeutics, a company mainly focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, recently opened its new 37,000 square foot clinical and early-stage commercial manufacturing facility. This is the first manufacturing facility in North America for the Shanghai-based corporation. CRB, a provder of sustainable engineering, architecture, construction and consulting solutions to the life sciences industry, spearheaded the design and c...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters